Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Profit After Tax (2018 - 2025)

Historic Profit After Tax for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $3.6 million.

  • Viemed Healthcare's Profit After Tax fell 781.05% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 million, marking a year-over-year increase of 3366.47%. This contributed to the annual value of $11.4 million for FY2024, which is 1138.34% up from last year.
  • As of Q3 2025, Viemed Healthcare's Profit After Tax stood at $3.6 million, which was down 781.05% from $3.2 million recorded in Q2 2025.
  • Viemed Healthcare's 5-year Profit After Tax high stood at $4.4 million for Q4 2024, and its period low was $967000.0 during Q2 2022.
  • Over the past 5 years, Viemed Healthcare's median Profit After Tax value was $2.3 million (recorded in 2023), while the average stood at $2.5 million.
  • As far as peak fluctuations go, Viemed Healthcare's Profit After Tax plummeted by 9193.28% in 2021, and later skyrocketed by 17668.25% in 2023.
  • Viemed Healthcare's Profit After Tax (Quarter) stood at $4.1 million in 2021, then plummeted by 40.35% to $2.4 million in 2022, then skyrocketed by 42.62% to $3.5 million in 2023, then grew by 27.24% to $4.4 million in 2024, then fell by 18.63% to $3.6 million in 2025.
  • Its Profit After Tax stands at $3.6 million for Q3 2025, versus $3.2 million for Q2 2025 and $2.7 million for Q1 2025.